• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用光谱CT门静脉与肝静脉碘密度差异对肝硬化患者肝功能进行无创评估:与Child-Pugh分级的相关性

Non-invasive assessment of liver function in cirrhosis using iodine density difference between the portal vein and hepatic vein on spectral CT: correlation with Child-Pugh grades.

作者信息

Yu Lu, Song Zhengping, Li Zhoulei, Lv Wen, Yang Fei, Li Xuehua, Sun Canhui

机构信息

Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Second Zhongshan Road, Yuexiu District, Guangzhou, 510080, People's Republic of China.

Department of Radiology, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, People's Republic of China.

出版信息

BMC Med Imaging. 2025 Jul 1;25(1):254. doi: 10.1186/s12880-025-01768-0.

DOI:10.1186/s12880-025-01768-0
PMID:40596902
Abstract

OBJECTIVE

To explore the feasibility and clinical significance of assessing liver function damage in patients with post-hepatitis cirrhosis using spectral CT by measuring the iodine density difference and CT value difference between the portal vein and hepatic vein.

METHODS

A study was conducted involving 65 patients with post-hepatitis cirrhosis (30 with Child-Pugh grade A, 28 with grade B, and 7 with grade C) and 82 healthy controls. All underwent dual-phase enhanced spectral CT scans of the upper abdomen. Post-processing with IntelliSpace Portal software yielded iodine density (ID), 45 keV virtual monoenergetic (VMI), and conventional CT (HU) images. The mean iodine densities of the portal vein (ID) and hepatic vein (ID) were measured, and the difference in ID (ID), VMI (VMI), and HU (HU) between the portal vein and hepatic vein was calculated. These values were compared between the control group and different Child-Pugh grades of cirrhosis, as well as between the compensated cirrhosis group (Child-Pugh grade A) and the decompensated cirrhosis group (grade B/C). The ability to diagnose decompensated cirrhosis was evaluated by plotting ROC curves.

RESULTS

The ID, VMI, and HU were significantly higher in the cirrhosis group compared to the control group and were also higher in the grade B/C group compared to the grade A group (all p<0.05). Among all patients with cirrhosis, the AUROC values for diagnosing grade B/C using ID, VMI, HU, NID, NVMI , and NHU were 0.774, 0.798, 0.736, 0.775, 0.774, and 0.757, respectively (all p < 0.05).

CONCLUSIONS

The iodine density difference (ID) and CT value difference (VMI and HU ) between the portal vein and hepatic vein, as measured by spectral CT, demonstrate a significant positive correlation with the Child-Pugh classification of liver function in cirrhotic patients. These quantitative parameters provide a simple and non-invasive approach for assessing liver function in cirrhotic patients.

CLINICAL TRIAL NUMBER

Not applicable.

摘要

目的

通过测量门静脉与肝静脉之间的碘密度差值及CT值差值,探讨采用光谱CT评估肝炎后肝硬化患者肝功能损害的可行性及临床意义。

方法

对65例肝炎后肝硬化患者(Child-Pugh A级30例、B级28例、C级7例)及82例健康对照者进行研究。所有受试者均接受上腹部双期增强光谱CT扫描。使用IntelliSpace Portal软件进行后处理,生成碘密度(ID)、45 keV虚拟单能量(VMI)及传统CT(HU)图像。测量门静脉(ID)和肝静脉(ID)的平均碘密度,并计算门静脉与肝静脉之间的ID差值(ΔID)、VMI差值(ΔVMI)及HU差值(ΔHU)。比较对照组与不同Child-Pugh分级肝硬化组之间以及代偿期肝硬化组(Child-Pugh A级)与失代偿期肝硬化组(B/C级)之间的这些值。通过绘制ROC曲线评估诊断失代偿期肝硬化的能力。

结果

肝硬化组的ID、VMI及HU均显著高于对照组,且B/C级组高于A级组(均p<0.05)。在所有肝硬化患者中,使用ID、VMI、HU、ΔID、ΔVMI及ΔHU诊断B/C级的曲线下面积(AUROC)值分别为0.774、0.798、0.736、0.775、0.774及0.757(均p<0.05)。

结论

光谱CT测量的门静脉与肝静脉之间的碘密度差值(ΔID)及CT值差值(ΔVMI和ΔHU)与肝硬化患者肝功能的Child-Pugh分级呈显著正相关。这些定量参数为评估肝硬化患者肝功能提供了一种简单且无创的方法。

临床试验编号

不适用。

相似文献

1
Non-invasive assessment of liver function in cirrhosis using iodine density difference between the portal vein and hepatic vein on spectral CT: correlation with Child-Pugh grades.利用光谱CT门静脉与肝静脉碘密度差异对肝硬化患者肝功能进行无创评估:与Child-Pugh分级的相关性
BMC Med Imaging. 2025 Jul 1;25(1):254. doi: 10.1186/s12880-025-01768-0.
2
Assessment of high-risk gastroesophageal varices in cirrhotic patients using quantitative parameters from dual-source dual-energy CT.利用双源双能量CT定量参数评估肝硬化患者的高危食管胃静脉曲张
Abdom Radiol (NY). 2024 Nov 15. doi: 10.1007/s00261-024-04666-1.
3
Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension.肝硬化及肝内非肝硬化性门静脉高压患儿门静脉血栓形成的患病率
Dig Liver Dis. 2025 Jul;57(7):1451-1454. doi: 10.1016/j.dld.2025.04.038. Epub 2025 May 10.
4
Potential of photon-counting detector CT technology for contrast medium reduction in portal venous phase thoracoabdominal CT.光子计数探测器CT技术在减少胸腹部CT门静脉期造影剂用量方面的潜力
Eur Radiol. 2025 Feb 12. doi: 10.1007/s00330-025-11409-3.
5
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
6
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.粒细胞集落刺激因子联合或不联合干细胞或祖细胞或生长因子输注治疗代偿期或失代偿期晚期慢性肝病患者。
Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2.
7
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.100 Hz 控制振动瞬时弹性成像测量脾脏硬度用于无创预测诊断代偿期慢性肝病进展期患者临床显著门静脉高压:模型研究。
Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1111-1120. doi: 10.1016/S2468-1253(24)00234-6. Epub 2024 Sep 23.
8
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
9
Methods of vascular occlusion for elective liver resections.选择性肝切除术中的血管阻断方法。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD006409. doi: 10.1002/14651858.CD006409.pub2.
10
WITHDRAWN: Methods of vascular occlusion for elective liver resections.撤回:择期肝切除术中的血管闭塞方法。
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006409. doi: 10.1002/14651858.CD006409.pub3.

本文引用的文献

1
Relative enhancement index can be used to quantify liver function in cirrhotic patients that undergo gadoxetic acid-enhanced MRI.相对增强指数可用于量化行钆塞酸增强 MRI 的肝硬化患者的肝功能。
Eur Radiol. 2023 Jul;33(7):5142-5149. doi: 10.1007/s00330-023-09402-9. Epub 2023 Jan 18.
2
Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.钆塞酸增强 MRI 衍生的功能性肝脏成像评分(FLIS)和脾脏直径可预测 ACLD 的结局。
J Hepatol. 2022 Oct;77(4):1005-1013. doi: 10.1016/j.jhep.2022.04.032. Epub 2022 May 4.
3
Ultrasonography in the diagnosis of complications in patients with portal hypertension.
超声检查在门静脉高压症患者并发症诊断中的应用
J Med Ultrason (2001). 2022 Jul;49(3):347-358. doi: 10.1007/s10396-021-01158-3. Epub 2021 Nov 17.
4
Liver fibrosis assessment: MR and US elastography.肝脏纤维化评估:磁共振和超声弹性成像。
Abdom Radiol (NY). 2022 Sep;47(9):3037-3050. doi: 10.1007/s00261-021-03269-4. Epub 2021 Oct 23.
5
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
6
Evidence-based clinical practice guidelines for liver cirrhosis 2020.《2020年肝硬化循证临床实践指南》
Hepatol Res. 2021 Jul;51(7):725-749. doi: 10.1111/hepr.13678. Epub 2021 Jul 6.
7
Hepatic parenchyma and vascular blood flow changes after TIPS with spectral CT iodine density in HBV-related liver cirrhosis.肝硬化患者行 TIPS 后门静脉频谱 CT 碘密度值与肝实质及血流变化的相关性。
Sci Rep. 2021 May 18;11(1):10535. doi: 10.1038/s41598-021-89764-6.
8
Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score.使用多期双能量CT碘图对肝硬化进行无创评估:与终末期肝病模型评分的相关性
Abdom Radiol (NY). 2021 May;46(5):1931-1940. doi: 10.1007/s00261-020-02857-0. Epub 2020 Nov 19.
9
Quantification of liver function using gadoxetic acid-enhanced MRI.使用钆塞酸增强 MRI 定量肝功能。
Abdom Radiol (NY). 2020 Nov;45(11):3532-3544. doi: 10.1007/s00261-020-02779-x. Epub 2020 Oct 9.
10
Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics.弥漫性肝病的形态学改变及影像学表现与肝内血流动力学的关系。
Jpn J Radiol. 2020 Sep;38(9):833-852. doi: 10.1007/s11604-020-00978-6. Epub 2020 Apr 28.